InsidersTradesSigma
Explore the full record of transactions filed by Sepp-Lorenzino Laura, Directeur Scientifique. Insider active across 1 companies, notably Intellia Therapeutics, Inc.. In total, 5 filings have been logged. The latest transaction was disclosed on 30 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations
Laura Sepp-Lorenzino is the Chief Scientific Officer at Intellia Therapeutics, Inc. She is responsible for leading scientific initiatives and research within the company. Laura Sepp-Lorenzino plays a key role in developing new therapies and scientific innovation. Her expertise in research is crucial for Intellia's mission.